IGF OT IGF SMOKESCREEN GENETIC SCREENING TOOL FOR TOBACCO DEPENDENCE and TREATMENT APPROACHES POP MOD SUPPLEMENT WITHIN SCOPE AND EXTENSION

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

• TOOLKIT FOR LEARNING AND PREDICTING ALCOHOL USE PATTERNS (SBIR PHASE II, TOPIC 019)
• SERVICES FOR CREATING A TOOLKIT FOR LEARNING AND PREDICTING ALCOHOL USE PATTERNS.
• Biosignatures of opioid addiction treatment success
• Smokescreen Translational (TL) Analysis Platform
• Smokescreen Translational (TL) Analysis Platform

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

• Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
• Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
• A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
• Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
• Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)

Research funding history

8 SBIR/STTR records share this UEI (2012–2023). Reported award amounts total $6,217,645. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards